RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a provider of orthopedic and other biologic implants, celebrated the ground breaking of its new 41,165-square-foot Logistics and Technology Center on Monday, Jan. 7.
Representatives from RTI Biologics, Inc., CPPI, and RS&H break ground on the new Logistics and Technology Center at the Alachua, Fla. headquarters. (Photo: Business Wire)
RTI, which is headquartered in Alachua, Fla., is one of the leading providers of sterile biologic implants for patients around the world. Its Logistics and Technology Center, a $14 million investment, will be home to the company’s research and development offices and laboratories, clean rooms, warehouse, shipping and finished implants and other support functions. In addition, the new facility will include space for production of RTI’s forthcoming map3™ cellular allogeneic bone grafts.
“RTI began operations in 1998 when it spun off from the University of Florida Tissue Bank. At that time, our offices, labs and clean rooms occupied approximately 45,000 square feet of total space in Progress Corporate Park, housing about 200 people,” said Brian K. Hutchison, RTI president and CEO. “Today we have more than 700 employees globally. This new facility represents the continued growth and expansion of our company and allows us room for future growth.”
The Logistics and Technology Center, along with the company’s recent acquisition of a 15,425 square foot office building in the park, will expand RTI’s total occupied space to about 200,000 square feet.“At RTI, we are committed to supporting the communities in which we operate and participating in the economic development of our regions,” said Hutchison. “We are excited to expand our facilities in Alachua, Fla. and are glad to be a part of a community that is focused on fostering innovation and success.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts